Rage fusion proteins
US8398977B2 · kind B2 · utility
21Cited by
14References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2008 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Mar 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel therapeutics and methods of treatment for diseases associated with activation of the advanced glycation endproducts receptor (RAGE).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.